Palliative Care for Mesothelioma: Earlier is Not Necessarily Better

palliative care for mesothelioma

New research suggests that palliative care for mesothelioma may be most helpful in later stages of the disease. Scientists in the UK and Australia say there is no reason for most mesothelioma patients to be referred to a palliative care specialist when they are diagnosed. As long as patients have access to palliative care when they need it, early referral does not seem to make much difference in quality of life. What is Palliative Care for Mesothelioma? Palliative care for mesothelioma aims to manage the symptoms of the disease and the treatment. Chest pain and shortness of breath are common symptoms of mesothelioma. Mesothelioma treatment can cause fatigue, nausea, and weight loss. Physical symptoms can cause depression or anxiety, which … Continue reading Palliative Care for Mesothelioma: Earlier is Not Necessarily Better »

MIT Study Could Open Door for Inhalable Mesothelioma Treatment

inhalable mesothelioma treatment tested on lab mice

New lung cancer research might help pave the way for an inhalable mesothelioma treatment. MIT cancer researchers teamed up with chemical engineers to test a new method for delivering genetic instructions to lung cells. Mice that inhaled a formula designed to “tell” their lung cells to produce more of a certain protein did exactly that. The team says it’s proof that this could be a viable method for treating cancer in the lungs. Pleural mesothelioma is a lung-related cancer caused by inhaled asbestos. How Would an Inhalable Mesothelioma Treatment Work? The study was led by scientists at MIT’s Koch Center for Integrative Cancer Research. It is based on two things scientists already know about cancer treatment. One is that inhalation … Continue reading MIT Study Could Open Door for Inhalable Mesothelioma Treatment »

Avelumab May Offer a Second-Line Option for Recurrent Mesothelioma

recurrent mesothelioma treatment

People with recurrent mesothelioma may get another chance at treatment with the immunotherapy drug avelumab. Malignant mesothelioma is highly resistant to standard cancer therapies. That means that the asbestos cancer usually comes back, or recurs, even after treatment. The most common treatment for mesothelioma is chemotherapy with Alimta. Alimta is the only drug approved specifically for mesothelioma. Patients with recurrent mesothelioma often have several rounds of chemotherapy with Alimta. But once the standard mesothelioma treatments stop working, patients do not have many options. Now a new study suggests that some cases of recurrent mesothelioma that stop responding to Alimta may respond to avelumab.   Considering Avelumab for Recurrent Mesothelioma Bavencio is the brand name for avelumab. It is a type … Continue reading Avelumab May Offer a Second-Line Option for Recurrent Mesothelioma »

Researchers Name Six Top Mesothelioma Survival Factors

Certain factors lead to longer mesothelioma survival

Researchers at the University of Pittsburgh have named what they say are the top six mesothelioma survival factors. According to their new study, patients with one or more of these factors tend to have better mesothelioma treatment outcomes and live longer. Malignant mesothelioma – also called asbestos cancer – is one of the deadliest forms of cancer. It starts on internal membranes and spreads quickly. There is no cure and the disease is very hard to slow down. Many mesothelioma patients die within 12 to 18 months. But there are cases of much longer mesothelioma survival. Some patients have even lived for decades after mesothelioma treatment. The Pittsburgh researchers wanted to find the mesothelioma survival factors shared by the longest … Continue reading Researchers Name Six Top Mesothelioma Survival Factors »

Treatment for Pericardial Mesothelioma: Chemotherapy is Best

treatment for pericardial mesothelioma

Some of the nation’s top cancer researchers say chemotherapy is the best treatment for pericardial mesothelioma.  Even surgery does not extend survival as well as chemotherapy. Doctors at the University of Texas reached that conclusion after studying more than 100 cases of pericardial mesothelioma. Surgery is still the most common treatment for pericardial mesothelioma. But the new research suggests that chemotherapy may be better. In the study, chemotherapy and cancer spread were the only factors that seemed to impact mesothelioma survival. What is Pericardial Mesothelioma? Malignant mesothelioma tumors grow on the linings around internal organs. The most common type is pleural mesothelioma which grows near the lungs. Peritoneal mesothelioma on the abdominal lining is the second most common type. Pericardial … Continue reading Treatment for Pericardial Mesothelioma: Chemotherapy is Best »

Chemotherapy for Mesothelioma May Work Better with TroVax

vaccine added to chemotherapy for mesothelioma

UK researchers say a cancer vaccine called Trovax has the potential to boost the power of chemotherapy for mesothelioma. Chemotherapy is the main treatment for malignant pleural mesothelioma. Mesothelioma is a cancer of the lung lining caused by asbestos exposure. It is very hard to treat. Even people who have chemotherapy for mesothelioma do not usually live more than two years after diagnosis. Mesothelioma researchers are always looking for ways to improve chemotherapy for mesothelioma. It is often combined with other treatments like surgery, radiation or immunotherapy. Now, scientists think adding TroVax to mesothelioma chemotherapy may be another good option. What is the TroVax Cancer Vaccine? The TroVax cancer vaccine is made by UK-based Oxford BioMedica. It contains an altered … Continue reading Chemotherapy for Mesothelioma May Work Better with TroVax »

Faster Mesothelioma Chemotherapy Deemed “Safe and Feasible”

faster mesothelioma chemotherapy

Researchers in The Netherlands say it may be possible to deliver faster mesothelioma chemotherapy without doing any additional damage to the kidneys. If they are right, it could make mesothelioma treatment more accessible and convenient for patients. Most malignant mesothelioma patients will have chemotherapy. The most common type of chemotherapy is by infusion. Each session takes several hours. Every mesothelioma patient undergoing chemotherapy faces the possibility of kidney damage. That possibility can even limit how much medicine doctors can use. But a new Dutch study finds that faster mesothelioma chemotherapy may be as safe for the kidneys as standard chemotherapy. Analyzing Faster Mesothelioma Chemotherapy The study included 230 lung cancer patients who had chemotherapy. Some of the study subjects had … Continue reading Faster Mesothelioma Chemotherapy Deemed “Safe and Feasible” »

Mesothelioma Staging May be Easier with New Approach

mesothelioma staging

Japanese researchers have introduced a new approach to mesothelioma staging. The new system may make it easier to plan treatment and predict mesothelioma prognosis. Tumor staging is a system for measuring how far cancer has spread in the body. It is based on what doctors know about how cancer develops and grows. The more places mesothelioma cells are, the more difficult the case is to treat. The TNM Staging System is the most widely used system for mesothelioma staging. The American Joint Committee on Cancer established the system. In the TNM system, T stands for the size of the primary mesothelioma tumor. N stands for the spread of cancer to the lymph nodes. M is about cancer spread to other … Continue reading Mesothelioma Staging May be Easier with New Approach »

Shortness of Breath Treatment Can ‘Seed’ New Mesothelioma Tumors

mesothelioma tumors in lungs

Mesothelioma patients who get pleural catheters to help with shortness of breath may pay a high price. New research shows about a quarter of them will develop new mesothelioma tumors at the spot where the catheter was placed. In a newly published paper, Canadian researchers say doctors need to consider the possibility of these catheter tract metastases (CTMs) when advising mesothelioma patients. Indwelling Pleural Catheters and Mesothelioma Many mesothelioma patients develop excess fluid around their lungs. This fluid puts pressure on the lungs and makes it hard for patients to get a deep breath. Shortness of breath is a common symptom of pleural mesothelioma. Indwelling pleural catheters (IPCs) can help. An IPC is a little tube inserted into the pleural … Continue reading Shortness of Breath Treatment Can ‘Seed’ New Mesothelioma Tumors »

Virotherapy for Mesothelioma Can Be More Effective

virotherapy for mesothelioma

Hong Kong researchers may have found a way to get around one of the biggest challenges of virotherapy for mesothelioma. Virotherapy uses a modified virus to deliver medicine or genetic information into the body. Modified viruses are useful because they can be “programmed” to seek out cancer cells. But modified viruses do not always behave the way scientists hope they will. One problem with some virotherapy for mesothelioma is that it can block the natural immune response. The body naturally fights malignant mesothelioma by releasing white blood cells called CTLs (T lymphocytes). But MVTT virotherapy can prevent the release of CTLs, even while it attacks the tumor. “Although MVTT [a type of virotherapy] leads to regression of established mesothelioma dose-dependently, … Continue reading Virotherapy for Mesothelioma Can Be More Effective »

Get your free copy of
“Surviving Mesothelioma” Today!